Owen Mumford announced today that it appointed Bal Johal as its director of research and development, effective next month.
Johal will become the director of R&D for the Woodstock, United Kingdom-based developer of medical devices, including the Aidaptus auto-injector, on July 4, 2022.
Get the full story at our sister site, Drug Delivery Business News.
Owen Mumford this week announced that it has started building its new production facility in Witney, Oxfordshire in the U.K.
Owen Mumford’s new Witney facility will stand as a production site for the company’s recently launched, next-generation auto-injector Aidaptus. The company has decades of experience creating its own drug delivery, blood sampling and rapid diagnostic products — as well as creating devices for major pharmaceutical and diagnostics companies.
Get the full story on our sister site, Medical Design & Outsourcing.